戻る
Vicapsys Life Sciences Inc (VICP) 収入
VICP 株価推移チャート
VICP 収入
Vicapsys Life Sciences Inc
$1.46
0%
$0
本日現在の状況：Apr 01, 12:25:14 GMT-4
データなしEarnings FAQ
VICPの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Vicapsys Life Sciences Inc VICPの前四半期の収益はどうでしたか？
Vicapsys Life Sciences Incの収益見積もりはいくらですか？
Vicapsys Life Sciences Incの収益品質スコアはどれくらいですか？
Vicapsys Life Sciences Incはいつ収益を報告しますか？
Vicapsys Life Sciences Incの予想収益はいくらですか？
Vicapsys Life Sciences Incは収益予想を上回りましたか？
主要データ
前終値
$1.46
始値
$1.5
当日レンジ
$0.51 - $1.5
52週レンジ
$0.15 - $1.77
取引高
100
平均取引高
21
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$47.2M
VICPとは何ですか？
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. The company is headquartered in Cumming, Georgia and currently employs 2 full-time employees. The company went IPO on 2001-07-11. VICAPSYN is the Company’s product line that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes (T1D) is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company also develops another product candidate line based on CXCL12 with the trade name of VYBRIN. The clinical applications of VYBRIN are being explored in several areas, including prevention of post-surgical adhesions in abdominal surgery, and others.